Integrated therapeutic strategies for anaplastic thyroid carcinoma

Related Experiment Video

Updated: Aug 27, 2026

Spontaneous Murine Model of Anaplastic Thyroid Cancer
05:39

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

Roberto Buzzoni1, Laura Catena, Diego Cortinovis

  • 1UO Oncologia Medica B, National Cancer Institute, Milan, Italy.

Tumori
|February 12, 2004
PubMed

Insights

Anaplastic thyroid carcinoma (ATC), a rare and aggressive cancer, has a poor prognosis with limited treatment options. Current research focuses on novel therapies and treatment timing to improve patient survival rates.

Area of Science:

  • Oncology
  • Endocrinology

Background:

  • Anaplastic thyroid carcinoma (ATC) is an exceptionally rare and aggressive thyroid neoplasm.
  • The prognosis for ATC has remained poor, with a median survival of approximately six months.
  • Curative treatment is typically limited to patients with incidentally discovered, localized ATC.

Purpose of the Study:

  • To review recent developments in the therapeutic options for anaplastic thyroid carcinoma.
  • To summarize emerging drugs and treatment timing strategies for ATC.

Main Methods:

  • Literature review of recent studies and clinical trials.
  • Synthesis of data on novel therapeutic approaches for ATC.

Main Results:

  • Exploration of various therapeutic options has yielded disappointing results to date.
  • New drugs and optimized treatment timing are currently under investigation.

Conclusions:

  • Despite extensive research, effective treatments for ATC remain elusive.
  • Ongoing investigations into novel drugs and treatment strategies offer potential for future improvement in ATC management.

More Related Videos

Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma06:08

Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma

Published on: June 2, 2023

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma07:01

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma

Published on: April 17, 2013

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...